Brief: Valneva SE Says CDC Updates Recommendation For Valneva's Chikungunya Vaccine
18/04/2025 09:09
April 18 (Reuters) - Valneva SE VLS.PA: VALNEVA PROVIDES UPDATE ON ACIP RECOMMENDATION FOR ITS CHIKUNGUNYA VACCINE IXCHIQ® AMONG U.S. TRAVELERS VALNEVA SE - CDC UPDATES RECOMMENDATION FOR VALNEVA'S CHIKUNGUNYA VACCINE VALNEVA SE - ACIP MAINTAINS RECOMMENDATION FOR IXCHIQ FOR TRAVELERS TO OUTBREAK AREAS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valneva SE
See all newsBrief: UK MHRA Withdraws Marketing Authorisation for Ixchiq Chikungunya Vaccine After Safety Review
Valneva falls as UK regulator revokes Ixchiq vaccine authorisation
Brief: Valneva Provides Update On Ixchiq® In The United Kingdom
Valneva surges after EU regulator validates Lyme disease vaccine application
Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency